- Home
- NUVB vs ORC Comparison
NUVB vs ORC Comparison
Compare NUVB & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- ORC
- Stock Information
- Founded
- NUVB 2018
- ORC 2010
- Country
- NUVB United States
- ORC United States
- Employees
- NUVB N/A
- ORC N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- ORC Real Estate Investment Trusts
- Sector
- NUVB Health Care
- ORC Real Estate
- Exchange
- NUVB Nasdaq
- ORC Nasdaq
- Market Cap
- NUVB 1.1B
- ORC 1.0B
- IPO Year
- NUVB N/A
- ORC 2013
- Fundamental
- Price
- NUVB $5.04
- ORC $7.66
- Analyst Decision
- NUVB Strong Buy
- ORC Hold
- Analyst Count
- NUVB 7
- ORC 2
- Target Price
- NUVB $8.43
- ORC N/A
- AVG Volume (30 Days)
- NUVB 8.2M
- ORC 5.3M
- Earning Date
- NUVB 11-03-2025
- ORC 10-23-2025
- Dividend Yield
- NUVB N/A
- ORC 18.85%
- EPS Growth
- NUVB N/A
- ORC N/A
- EPS
- NUVB N/A
- ORC 0.57
- Revenue
- NUVB $14,355,000.00
- ORC $80,187,000.00
- Revenue This Year
- NUVB $291.13
- ORC $75.23
- Revenue Next Year
- NUVB $332.00
- ORC $53.72
- P/E Ratio
- NUVB N/A
- ORC $13.35
- Revenue Growth
- NUVB 900.35
- ORC 5.93
- 52 Week Low
- NUVB $1.54
- ORC $5.69
- 52 Week High
- NUVB $5.12
- ORC $9.01
- Technical
- Relative Strength Index (RSI)
- NUVB 76.90
- ORC 71.38
- Support Level
- NUVB $3.36
- ORC $7.40
- Resistance Level
- NUVB $3.84
- ORC $7.57
- Average True Range (ATR)
- NUVB 0.29
- ORC 0.14
- MACD
- NUVB 0.11
- ORC 0.04
- Stochastic Oscillator
- NUVB 95.45
- ORC 83.33
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.